ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 27.92.
| Share Price | ₹5,150.0 | Nov 02,2026 |
| Market Cap | ₹61,594.0 Cr | |
| Earnings-TTM | ₹2,206.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 27.92x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹61,594.0 Cr] as on Nov 02,2026
(/) Earnings [ ₹2,206.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 27.92x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 27.92 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 30.98x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 27.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 26.28x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,206.30 | 27.92 | 61,594.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 38.43 | 424,202.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 90.30 | 264,141.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 83.09 | 174,402.0 |
| CIPLA LTD | 2,868.29 | 38.93 | 111,650.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 40.54 | 111,868.0 |
| MANKIND PHARMA LTD | 2,249.69 | 45.43 | 102,196.0 |
| LUPIN LTD | 5,551.01 | 16.45 | 91,300.8 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 27.53 | 123,685.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.11 | 96,951.2 |
| LAURUS LABS LTD | 1,333.75 | 95.08 | 126,811.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.45x |
| Max industry PE | 95.08x |
| Median industry PE | 38.93x |
| Average industry PE | 48.16x |
You may also like the below Video Courses